The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Sep 12. DOI:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273–1275.
   PubMed Web of Science ®Google Scholar
• Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to pylori. Int J Cancer. 2015;136:487–490.
   PubMed Web of Science ®Google Scholar
• World Health Assembly. World Health Assembly Resolution: completion of polio eradication programmatic emergency for global public health, 2012.
   Google Scholar
• Callaway E. Public health: polio’s moving target. Nature. 2013;496:290–292.
   PubMed Web of Science ®Google Scholar
• Fenner F, Henderson DA, Arita I, et al. Smallpox and Its Eradication. Geneva, Switzerland: World Health Organization; 1988.
   Google Scholar
• Zeng M, Mao XH, Li JX, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386:1457–1464.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Selgard M, Wex T, et al. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018;S2468–1253:30125–30130.
   Google Scholar
• Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–5204.
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Di Mario F, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15:1833–1843.
   PubMed Web of Science ®Google Scholar
• IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8). 2014. Available from: http://www.gastro-health-now.org/wp/wp-content/uploads/2014/09/WHO-IARC-Report-2014.pdf.
   Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646–664.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–1367.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Kao JY, Kanwal F, et al. Houston Consensus Conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol. 2018;16:992–1002.
   PubMed Web of Science ®Google Scholar
• Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–1124.
   PubMed Web of Science ®Google Scholar
• Graham DY. Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med. 2015;30:133–139.
   PubMed Web of Science ®Google Scholar
• Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–397.
   PubMed Web of Science ®Google Scholar
• Yoon SB, Park JM, Lim CH, et al. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014;19:243–248.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–1095.
   PubMed Web of Science ®Google Scholar
• Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148:719–731.
   PubMed Web of Science ®Google Scholar
• Lee YC, Tseng PH, Liou JM, et al. Performance of a one-step fecal sample-based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings. J Formos Med Assoc. 2014;113:899–907.
   PubMed Web of Science ®Google Scholar
• Kikuchi S, Kato M, Katsuyama T, et al. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter. 2006;11:147–151.
   PubMed Web of Science ®Google Scholar
• Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44:693–697.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445–1457.
   PubMed Web of Science ®Google Scholar
• Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–768.
   PubMed Web of Science ®Google Scholar
• Zagari RM, Rabitti S, Greenwood DC, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46:657–667.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chiu SY, Chen SL, et al. Serum pepsinogen as a predictor for gastric cancer death: A 16-year community-based cohort study. J Clin Gastroenterol. 2018 Jan 23. DOI:10.1097/MCG.0000000000000992.
   PubMedGoogle Scholar
• Dore MP, Cipolli A, Ruggiu MW, et al. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: a retrospective study. Medicine (Baltimore). 2018;97(4):e9734.
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27:933–947.
   PubMed Web of Science ®Google Scholar
• Lee YC, Lin JT, Wu HM, et al. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:875–885.
   PubMed Web of Science ®Google Scholar
• Yeh JM, Kuntz KM, Ezzati M, et al. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009;124:157–166.
   PubMed Web of Science ®Google Scholar
• Ford AC, Delaney BC, Forman D, et al. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol. 2004;99:1833–1855.
   PubMed Web of Science ®Google Scholar
• Sugano K. Strategies for prevention of gastric cancer: progress from mass eradication trials. Dig Dis. 2016;34:500–504.
   PubMed Web of Science ®Google Scholar
• Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013;62:676–682.
   PubMed Web of Science ®Google Scholar
• Screening for stomach diseases and colorectal neoplasms with the fecal testing. [cited 2018 Sep 17]. The study protocol is available from: https://clinicaltrials.gov/ct2/show/NCT01741363
   Google Scholar
• Saumoy M, Schneider Y, Shen N, et al. Cost effectiveness of gastric cancer screening according to race and ethnicity. Gastroenterology. 2018;S0016–5085:34546–34553.
   Google Scholar
• Lee YC, Asaka M, Graham DY. Editorial: Helicobacter pylori and gastric cancer in Alaskan Natives: time to stop studying H. pylori and to eradicate it. Helicobacter. 2018;23:e12478.
   PubMed Web of Science ®Google Scholar
• Pasechnikov V, Chukov S, Fedorov E, et al. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20:13842–13862.
   PubMed Web of Science ®Google Scholar
• Leja M, You W, Camargo MC, et al. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093–1106.
   PubMed Web of Science ®Google Scholar
• Lee YC, Hsu CY, Chen SL, et al. Effects of screening and universal healthcare on long-term colorectal cancer mortality. Int J Epidemiol. 2018 Sep 3. DOI:10.1093/ije/dyy182.
   Google Scholar
• Sheu BS, Wu MS, Chiu CT, et al. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter. 2017;22. DOI:10.1111/hel.12368.
   Web of Science ®Google Scholar
• Lee YC, Chiang TH, Liou JM, et al. Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations. Gut Liver. 2016;10:12–26.
   PubMed Web of Science ®Google Scholar
• Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2018 Jan 6. pii: gutjnl-2017-314600. DOI:10.1136/gutjnl-2017-314600.
   Google Scholar
• Hurst AF. Schorstein lecture on the precursors of carcinoma of the stomach. Lancet. 1929;214:1023–1028.
   Google Scholar